Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.55 -0.28 (-9.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) Shares Outstanding (Entity) (2013 - 2026)

Updated

Matinas BioPharma Holdings (MTNB) posted Shares Outstanding (Entity) of 6.41 million for Q2 2026, up 25.9% from 5.09 million a year earlier and unchanged from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

Since Q1 2013, Matinas BioPharma Holdings has reported Shares Outstanding (Entity) for 54 quarters.

  • Annual Shares Outstanding (Entity) shows a five-year compound annual growth rate of -49.8% (FY2020 to FY2025).
  • In prior years, Matinas BioPharma Holdings' Shares Outstanding (Entity) was 5.09 million in FY2024 (-97.7%), 217.26 million in FY2023 (unchanged), 217.26 million in FY2022 (+0.5%) and 216.27 million in FY2021 (+8.1%).
  • Quarterly Shares Outstanding (Entity) has run from a low of 5.09 million in Q3 2024 to a high of 250.82 million in Q2 2024 over five years.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last four quarters, with an average decline of 37.1% over the last eight quarters.
  • The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q2 2026, with growth of 25.9%; the weakest was Q2 2025, with a decline of 98.0%.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 6.41 million (Q1 2026), 6.41 million (Q4 2025) and 5.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Matinas BioPharma Holdings 16.34 Mn 3.74 Mn - 6.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.41 Mn
Mar 31, 2026 6.41 Mn
Dec 31, 2025 6.41 Mn
Sep 30, 2025 5.90 Mn
Jun 30, 2025 5.09 Mn
Mar 31, 2025 5.09 Mn
Dec 31, 2024 5.09 Mn
Sep 30, 2024 5.09 Mn
Jun 30, 2024 250.82 Mn
Mar 31, 2024 217.48 Mn
Dec 31, 2023 217.26 Mn
Sep 30, 2023 217.26 Mn
Jun 30, 2023 217.26 Mn
Mar 31, 2023 217.26 Mn
Dec 31, 2022 217.26 Mn
Sep 30, 2022 216.86 Mn
Jun 30, 2022 216.86 Mn
Mar 31, 2022 216.86 Mn
Dec 31, 2021 216.27 Mn
Sep 30, 2021 216.25 Mn
API Access

Matinas BioPharma Holdings Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MTNB&period=max&api_key=YOUR_API_KEY